QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD – Trademark Portfolio

Entity Type: 99

QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FUTUNE SCIENCE. The owner is based in QINGDAO, SHANDONG.

No.17 LIANGJlANG ROAD,LIUTING

QINGDAO, SHANDONG 266000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD have?

QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD file in?

QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD's most well-known trademarks?

QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD's registered trademark portfolio includes well-known marks such as FUTUNE SCIENCE. These are among 1 currently registered trademark in the portfolio.

What is QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD's trademark registration success rate?

QINGDAO FUTUNE SCIENCE AND TECHNOLOGY CO.,LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.